Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease-Reference-Cited by-同舟云学术

Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease

Published:2021-05-20 Issue:1 Volume:63 Page:117-124
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Biechele Gloria,Monasor Laura Sebastian,Wind Karin,Blume Tanja,Parhizkar Samira,Arzberger Thomas,Sacher Christian,Beyer Leonie,Eckenweber Florian,Gildehaus Franz-Josef,von Ungern-Sternberg Barbara,Willem Michael,Bartenstein Peter,Cumming Paul,Rominger Axel,Herms Jochen,Lichtenthaler Stefan F.,Haass Christian,Tahirovic Sabina,Brendel Matthias

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference28 articles.

1. Amyloid duration is associated with preclinical cognitive decline and tau PET

2. NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease

3. Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials;Wessels;JAMA Neurol.,2020

4. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

5. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease;Molecular Neurobiology;2024-03-19

2. Associations between sex, body mass index and the individual microglial response in Alzheimer’s disease;Journal of Neuroinflammation;2024-01-23

3. In Vivo Near-Infrared Fluorescence Imaging Selective for Soluble Amyloid β Aggregates Using y-Shaped BODIPY Derivative;Journal of Medicinal Chemistry;2023-10-12

4. [18F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data;Journal of Neuroinflammation;2023-03-11

5. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective;European Journal of Nuclear Medicine and Molecular Imaging;2023-03-04